A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Haematologica(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined